CDC Endorses GSK, Pfizer RSV Vaccines for Older Adults
The 2 new vaccines are authorized for adults aged 60 years and older and with CDC Director Walensky's final nod, should be available this fall.
FDA Advisory Committee Unanimous: COVID-19 Vaccines Should be Monovalent, Contain XBB Strain
The FDA's VRBPAC members were unanimous in their recommendation that the 2023-24 COVID vaccines reflect the dominant strain in circulation, XBB.
Nirsevimab Gets FDA Advisory Committee Recommendation to Prevent RSV in Infants
Nirsevimab, a long-acting monoclonal antibody, if approved, will be indicated to prevent RSV LRTD in neonates and infants born during or entering into their first RSV season.
Study Finds COVID-19 Neutralizing Antibody Response Differs by Vaccine Type
Neutralizing antibodies were lowest among Janssen volunteers at 1 month post-vaccination but at 6 months afterward, the picture was much different.
Antibiotics Unlikely to Save Lives of Patients Hospitalized with Respiratory Infections
In most patients with viral respiratory infections, the chance of bacterial coinfection is low and antibiotics can be withheld safely, say authors of a new study.
Candida auris: US Case Count Rising Rapidly
Drug-resistant cases of Candida auris continue to spread across the US after an alarming 95% rise in cases of the fungal infection in 2021.
Novel Nasally-administered Monoclonal Antibody Reduces Inflammation in COVID-19
Delivered intranasally, the fully human anti-CD3 mAb Foralumab modulated T-cell inflammation in COVID-19 and may have wider application, say study authors.
COVID-19 Reinfection: Snapshot of the Pathology
Data presented at CROI 2023 demonstrated that periods of reinfection with the virus correlated with ascent of new variants and with time since first infection.
COVID-19 Vaccines, Boosters, Prior Infection Significantly Reduce Risks, but Immunity Wanes
A large cohort study confirms the observed efficacy of initial and follow-up COVID-19 vaccination and prior infection against infection, hospitalization, and death.
New CDC COVID-19 Guidelines Reduce Quarantine Requirement after Exposure
After exposure to COVID-19, asymptomatic individuals in low-risk settings no longer need to quarantine, says the CDC; masking is still recommended.
Monkeypox: WHO Declares Public Health Emergency of International Concern
The WHO's highest level of alert indicates the organization's belief that the now multicountry monkeypox outbreak requires a coordinated international response.
Monkeypox Treatments May be Close at Hand
There are no specific drugs to treat the monkeypox virus but research into existing antivirals is well under way to determine their potential efficacy.
CDC Elevates Monkeypox Alert to Level 2, Encourages "Enhanced Precautions"
The CDC raised its monkeypox alert to a level 2 on June 6, reporting more than 1000 cases worldwide and 25 infections confirmed in 12 US states and DC.
Monkeypox: What We Know About the Outbreak Now
The CDC reported 1 confirmed case of monkeypox in Massachusetts on May 23rd; Quebec is investigating 17 suspected cases. Find out what we know now about the virus.
